Search / Trial NCT06613074

Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients with Acute Ischemic Stroke

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Sep 23, 2024

Trial Information

Current as of October 07, 2024

Not yet recruiting

Keywords

Reperfusion Therapy Pre Hospital Triage

Description

According to the Bigdata Observatory platform for Stroke of China (BOSC), the proportion of patients with acute ischemic stroke (AIS) receiving intravenous thrombolysis or endovascular treatment in China is 5.64% and 1.45% respectively. One of the important reasons for the low treatment rate is the prolonged pre-hospital and in-hospital delay. Besides, for patients receiving reperfusion therapy, the prolonged pre-treatment delay is associated with unfavorable functional outcomes. Although tons of efforts have been made to improve the efficiency of emergency medical system in the transporta...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients diagnosed as acute ischemic stroke undergoing reperfusion therapy within 24 hours of onset
  • Exclusion Criteria:
  • * Patients transported to hospitals via emergency medical service
  • * Patients with in-hospital stroke

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0